跳至主要内容
临床试验/NCT00306683
NCT00306683已完成3 期

Clinical Assessment of the Treatment With Diazoxide in Children Suffering From Obesity and Hyperinsulinemia Secondary to Surgery of Hypothalamic-pituitary Lesions

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2006年4月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Relative weight change over two months

研究概览

简要总结

In children treated for intracranial lesions, the 2 factors of the obesity are : the location of the lesion (hypothalamic-pituitary region) and craniopharyngiomas

详细描述

Approximately 80 % of the hypothalamic-pituitary lesions that occur in children are craniopharyngiomas with one or three cases per 1 million children each year.

One major problem remains unsolved : the obesity

This study is performed to optimize the management of the children with hypothalamic-pituitary lesions by reducing the hyperinsulinemia due to the lesion and the surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 6 to 18 years
  • •Obesity with body mass index > 97 percentile or > 2 SD
  • •Hypothalamic-pituitary lesions not evolutive
  • •Hyperinsulinemia defined by insulin peak after oral glucose tolerance test>100 UI/L
  • •Absence of diabetes mellitus defined by basal plasma glucose < 1.2 g/L and glucose peak after oral glucose tolerance test < 2 g/L and HbA1c < 7 %
  • •Hormonal replacement therapy stable from at least three months excluding the treatment of diabetes insipidus which can be adjusted
  • •Normal plasma thyroxine
  • •Written informed consent of the children and the parents

排除标准

  • •evolutive lesion
  • •recent surgery or radiotherapy (< 6 months)
  • •modification of hormonal replacement therapy during the three previous months
  • •diabetes mellitus defined by basal plasma glucose > 1.2 g/L and glucose peak after oral glucose tolerance test > 2 g/L and HbA1c > 7 %
  • •renal or hepatic failure
  • •uncontrolled hypertension
  • •hypersensitivity to benzothiazine drugs
  • •pregnancy
  • •difficulties to understand the protocol

结局指标

主要结局

Relative weight change over two months

时间窗: 2 months

Relative weight change over two months

(Weight at Day 1 - Weight at Day 60)/Weight at Day 1

次要结局

  • Absolute weight change over two months
  • Decrease of hyperinsulinemia
  • Decrease of the glucose peak after oral glucose tolerance test (OGTT)
  • Evolution of HbA1c

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验